Clinical Trial Update: Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of ARQ-154 Foam in adolescent and adult subjects with plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ARQ-154 Foam

Snippet

Sponsor: Arcutis Biotherapeutics, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-09-30